Company logo

BYSI - BeyondSpring Inc.

NASDAQ -> Healthcare -> Biotechnology
New York, United States
Type: Equity

BYSI price evolution
BYSI
(in millions $) 31 Jan 2023 30 Jul 2022 30 Dec 2021 29 Sep 2021
Current assets
Cash $41.63 $63.43
Short term investments $17.57 $28.17
Net receivables
Inventory
Total current assets $38.52 $55.73 $75.12 $94.67
Long term investments
Property, plant & equipment $7.35 $7.92 $3.41 $2.33
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $46.22 $63.77 $81.65 $98.37
Current liabilities
Accounts payable $1.08 $1.16 $1.66 $2.13
Deferred revenue
Short long term debt $1.57 $1.55
Total current liabilities $7.35 $11.11 $15.15 $18.56
Long term debt
Total noncurrent liabilities
Total debt
Total liabilities $52.2 $55.66 $55.27 $59.21
Shareholders' equity
Retained earnings -$375.28 -$360.49 -$342 -$332.48
Other shareholder equity $0.44 $0.12 -$0.52 -$0.4
Total shareholder equity $26.68 $38.33
(in millions $) 31 Jan 2023 30 Dec 2021 30 Dec 2020 30 Dec 2019
Current assets
Cash $41.63 $109.54 $35.93
Short term investments $17.57
Net receivables $3.5 $4.5
Inventory
Total current assets $38.52 $75.12 $113.4 $40.86
Long term investments
Property, plant & equipment $7.35 $3.41 $2.36 $2.75
Goodwill & intangible assets
Total noncurrent assets $3.64 $3.69
Total investments
Total assets $46.22 $81.65 $117.04 $44.55
Current liabilities
Accounts payable $1.08 $1.66 $2.22 $2.54
Deferred revenue $1.35
Short long term debt $1.57
Total current liabilities $7.35 $15.15 $13.77 $10.05
Long term debt $2.17 $1.44
Total noncurrent liabilities $16.65 $3.37
Total debt
Total liabilities $52.2 $55.27 $25.22 $13.42
Shareholders' equity
Retained earnings -$375.28 -$342 -$277.82 -$216.84
Other shareholder equity $0.44 -$0.52 -$0.3 $0.14
Total shareholder equity $26.68 $88.34 $30.28
(in millions $) 31 Jan 2023 30 Jul 2022 31 Jan 2022 29 Sep 2021
Revenue
Total revenue $1.35 $0.68 $0.34
Cost of revenue
Gross Profit $0.34
Operating activities
Research & development $8.46
Selling, general & administrative $10.23
Total operating expenses $38.59 $21.48 $18.69
Operating income -$18.35
Income from continuing operations
EBIT -$18.35
Income tax expense $0.16 $0.29 $2.59
Interest expense -$0.25 -$0.33 -$0.02
Net income
Net income -$33.28 -$18.49 -$18.37
Income (for common shares) -$18.37
(in millions $) 31 Jan 2023 31 Jan 2022 30 Dec 2020 30 Dec 2019
Revenue
Total revenue $1.35 $0.18
Cost of revenue
Gross Profit $0.18
Operating activities
Research & development $41.79 $31.34
Selling, general & administrative $22.6 $8.96
Total operating expenses $38.59 $64.39 $40.31
Operating income -$64.21 -$40.31
Income from continuing operations
EBIT -$64.21 -$40.31
Income tax expense $0.16
Interest expense -$0.25 -$0.09 -$0.21
Net income
Net income -$33.28 -$60.97 -$38.09
Income (for common shares) -$60.97 -$38.09
(in millions $) 31 Jan 2023 30 Dec 2021 29 Sep 2021 30 Jul 2021
Net income -$9.51 -$18.37 -$37.34
Operating activities
Depreciation $0.01 $0.02
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$16.92 $2.83 -$33.15
Investing activities
Capital expenditures -$2.81 -$0.02
Investments -$1.92 $9.36
Total cash flows from investing $18.25 -$4.73 $9.34 -$25.02
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $3.43 $0
Effect of exchange rate -$0.76 -$0.16 -$0.04 -$0.06
Change in cash and equivalents -$7.23 -$21.81 $12.13 -$58.23
(in millions $) 31 Jan 2023 30 Dec 2021 30 Dec 2020 30 Dec 2019
Net income -$64.18 -$60.97 -$38.09
Operating activities
Depreciation $0.06 $0.08 $0.08
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$47.24 -$43.74 -$48.16
Investing activities
Capital expenditures -$2.84 -$0.05 -$0
Investments -$17.57
Total cash flows from investing $18.25 -$20.41 -$0.05 -$0
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $0.61 $1.52
Total cash flows from financing $3.43 $0 $117.83 $80.17
Effect of exchange rate -$0.76 -$0.26 -$0.43 $0.04
Change in cash and equivalents -$7.23 -$67.91 $73.6 $32.04
Fundamentals
Market cap $46.32M
Enterprise value N/A
Shares outstanding 38.93M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q 299.70%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 5.24
Quick ratio N/A